crinecerfont

chemical compound

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

  • Englishcrinecerfont
  • FrançaisCrinecerfont

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Crinecerfont, sold under the brand name Crenessity, is a medication used for the treatment of congenital adrenal hyperplasia. It is a corticotropin-releasing factor type 1 receptor (CRF1R) antagonist developed to treat classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD). It is taken by mouth.

The most common side effects of crinecerfont in adults include fatigue, dizziness, and arthralgia (joint pain). For children, the most common side effects include headache, abdominal pain, and fatigue. Crinecerfont was approved for medical use in the United States in December 2024.

The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1364270559 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot crinecerfont-3048817-ad20a57c22a6510c · hash ad20a57c22a6510cf0f20786fd44503284663ebee1a645c38efca996fa245082 · captured 2026-07-15 · ledger · version history

Cite this page as: encyclopegia.org, “crinecerfont”, snapshot crinecerfont-3048817-ad20a57c22a6510c. https://encyclopegia.org/a/crinecerfont

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.